The Role of Procalcitonin in Differentiating Between Gram-Negative and Gram-Positive Sepsis
Procalcitonin in Gram-Negative and Gram-Positive Sepsis
DOI:
https://doi.org/10.5281/zenodo.14032461Keywords:
C-reactive protein, gram-positive bacteria, gram-negative bacteria, procalcitonin, sepsisAbstract
Introduction: Detecting the agent group in sepsis patients with culture positivity is crucial in determining our treatment scheme. We aimed to evaluate the diagnostic accuracy of procalcitonin (PCT) levels in distinguishing between different pathogen groups in sepsis patients with proven bacteremia.
Materials & Methods: Records of patients hospitalized in ICU were retrospectively investigated over 28 were retrospectively investigated confirmed microbiologically to have a positive blood culture result. The patients were evaluated in two groups regarding gram-negative (GN) and gram-positive bacteria based on the findings of blood culture and Gram staining. Age, gender, APACHE II score, hospital stay, mortality, and laboratory parameters were compared in both groups. Of 894 patients followed up in ICU during 28 months, 56 sepsis patients confirmed microbiologically to have blood culture positivity were included.
Results: While GN bacteria grew in the blood cultures of 26 (46.4%) patients, 30 (53.6%) patients were found to have GP bacteria. The level of PCT was significantly higher in the GN group, compared to that of the GP group (p=0.003). There were no significant differences in CRP values and APACHE II scores between the GN and GP groups (p=0.147 and p=0.633, respectively). Additionally, no statistically significant difference was determined between the GN and GP groups regarding the mortality rate (p=0.712). Leukocyte, neutrophil, lymphocyte, platelet, and albumin values of both groups were also similar.
Conclusionː PCT was found to be a useful marker in predicting the pathogen groups in early treatment management of patients diagnosed with sepsis.
Downloads
References
. Cohen J, Vincent JL, Adhikari NK, Machado FR, Angus DC, Calandra T, et al. Sepsis: a roadmap for future research. Lancet Infect Dis. 2015;15(5):581-614. doi: 10.1016/S1473-3099(15)70112-X.
Vazquez-Grande G, Kumar A. Optimizing antimicrobial therapy of sepsis and septic shock: Focus on antibiotic combination therapy Semin Respir Crit Care Med. 2015;36:154–66 future research Lancet Infect Dis. 2015;15:581–614.
Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis Lancet Infect Dis. 2013;13:426–35.
Yıldırım F, ŞimŞek M. Gram negatif ve gram pozitif sepsis. Ortaç Ersoy NE, editör. Sepsis. 1. Baskı. Ankara: Türkiye Klinikleri; 2021;62-66.
-Leli C, Ferranti M, Moretti A, Al Dhahab ZS, Cenci E, Mencacci A. Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers 2015; 2015: 701480.
Nakajima A, Yazawa J, Sugiki D, Mizuguchi M, Sagara H, Fujisiro M, et al. Clinical utility of procalcitonin as a marker of sepsis: A potential predictor of causative pathogens Intern Med. 2014;53:1497–503.
Marková M, Brodská H, Malícková K, Válková V, Cetkovský P, Kolár M, et al. Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to the diagnosis of fungal infection in immunocompromised patients Support Care Cancer. 2013;21:2733–42.
Brodská H, Malícková K, Adámková V, Benáková H, Štastná MM, Zima T. Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis Clin Exp Med. 2013;13:165–70.
Opal SM, Cohen J. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med. 1999;27(8):1608–1616. doi: 10.1097/00003246-199908000-00039.
Reinhart K., Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin. 2011;27:253-263.
Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, et al. Gram-negative bacteremia induces a greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care 2010; 14: R27.
Vandijck DM, Hoste EA, Blot SI, Depuydt PO, Peleman RA, Decruyenaere JM. Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram-positive vs. Gram-negative bacteremia: a historical cohort study. BMC Infect Dis. 2007;14(7):106. doi: 10.1186/1471-2334-7-106.
Li S, Rong H, Guo Q, Chen Y, Zhang G, Yang J. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci. 2016;14:21-39. doi: 10.4103/1735-1995.183996.
Bilgili B, Haliloğlu M, Süzer Aslan M, Sayan İ, Kasapoğlu US, Cinel İ. Diagnostic Accuracy of Procalcitonin for Differentiating Bacteraemic Gram-Negative Sepsis from Gram-Positive Sepsis. Turk J Anaesthesiol Reanim 2018; 46: 38-43.
Alıcı A, Çetin Ş, Çetin M, Dörtok H. [The role of procalcitonin and C-reactive protein in prediction of etiology of bloodstream infections]. Klimik Derg. 2023;36(4):268-73.
Liu HH, Zhang MW, Guo JB, Li J, Su L. Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria. Ir J Med Sci. 2017;186(1):207-212. doi: 10.1007/s11845-016-1457-z.
Peng TT, Liu YH, Xuan K. Relationship between inflammatory factors, endotoxin changes, and bacterial type and condition in sepsis patients. Chin J Nosocomiol. 2021;30(4):487–491.
Chen W, Zhao L, Niu S, Wang S, Sheng B, Zhen J, et al. The diagnostic value of different pro-inflammatory factors in early diagnosis of sepsis in patients with bloodstream infection. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26(3):165–170.
Nešković N, Drenjančević D, Kvolik S, Škiljić S, Budrovac D, Drenjančević IH. Predictive role of selected biomarkers in differentiating gram-positive from gram-negative sepsis in surgical patients: a retrospective study. Anaesthesiol Intensive Ther. 2023;55(5):319-325. doi: 10.5114/ait.2023.134214.
Tang A, Shi Y, Dong Q, Wang S, Ge Y, Wang C, Gong Z, Zhang W, Chen W. Prognostic differences in sepsis caused by gram-negative bacteria and gram-positive bacteria: a systematic review and meta-analysis. Crit Care. 2023 Nov 30;27(1):467. doi: 10.1186/s13054-023-04750-w.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Chronicles of Precision Medical Researchers
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
